Atg5 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
ATG5 (Autophagy Related 5) is a core autophagy protein essential for the formation of autophagosomes. It is a key component of the ATG12-ATG5 conjugation system, which is required for autophagosome biogenesis. ATG5 plays critical roles in cellular homeostasis and has been implicated in various neurodegenerative diseases including Alzheimer's, Parkinson's, and Huntington's disease.
ATG5 is a ~282 amino acid protein:
- Molecular weight: ~32 kDa
- Ubiquitin-like fold: Contains an ubiquitin-like fold for conjugation
- Interaction domains: Interacts with ATG12, ATG16L1, and Fas-associated death domain (FADD)
- ATG5 forms a covalent conjugate with ATG12
- This conjugation is irreversible and essential for autophagy
- ATG12-ATG5 then binds ATG16L1 to form the ATG12-ATG5-ATG16L1 complex
ATG5 is central to autophagy:
- Autophagosome formation: Essential for the expansion and closure of the autophagosome
- ATG12-ATG5-ATG16L1 complex: Functions as an E3-like enzyme for LC3 lipidation
- Selective autophagy: Involved in receptor-mediated selective autophagy
- Pre-autophagosomal structure (PAS): Critical for PAS organization
- Apoptosis regulation: ATG5 can be cleaved by calpains to generate a pro-apoptotic fragment
- Immune signaling: Regulates type I interferon signaling
- Mitochondrial quality control: Essential for mitophagy
- ATG5 deficiency enhances amyloid-β accumulation
- Impaired autophagic flux observed in AD brains
- Reduced ATG5 expression correlates with disease severity
- ATG5 mutations associated with PD risk
- Essential for mitophagy of damaged mitochondria
- Impaired mitophagy contributes to dopaminergic neuron loss
- Mutant huntingtin impairs ATG5-mediated autophagy
- ATG5 overexpression reduces mutant huntingtin aggregation
- Therapeutic potential of autophagy enhancement
- Dysregulated autophagy in motor neurons
- ATG7 and ATG5 deficiency accelerates disease progression
| Approach |
Status |
Description |
| Autophagy enhancers |
Research |
Rapamycin, carbamazepine, rilmenidine |
| ATG5 expression |
Research |
Gene therapy to enhance ATG5 levels |
| Small molecule activators |
Preclinical |
Activate autophagy via mTOR-independent pathways |
- ATG5 is essential for autophagosome formation - Mizushima N et al., Cell 1998
- ATG5 in neurodegeneration - Nishiyama J et al., Nat Rev Neurosci 2010
- ATG5 in mitophagy and Parkinson's disease - Liu J et al., Nat Neurosci 2019
ATG5 is central to autophagy:
- Conjugation system: Forms ATG5-ATG12 conjugate
- Phagophore expansion: Required for autophagosome formation
- LC3 lipidation: Facilitates ATG5-ATG12 as E3 ligase
- Selective autophagy: Works with receptor proteins
The ATG5-ATG12 conjugate:
- Forms via ATG7 (E1) and ATG10 (E2) enzymes
- Essential for autophagosome biogenesis
- Acts as E3-like enzyme for LC3/GABARAP lipidation
- Required for both bulk and selective autophagy
ATG5 is regulated by:
- Transcriptional control
- Post-translational modifications
- Apoptotic cleavage (inactivates function)
- Interactions with viral proteins
ATG5 dysfunction in:
- Alzheimer's disease: Impaired autophagic clearance
- Parkinson's disease: Reduced mitophagy
- ALS: Aggregate clearance defects
- Often overexpressed in cancers
- May support tumor survival
- Autophagy can be protective or promotional
| Approach |
Mechanism |
Disease |
Status |
| Autophagy inducers |
mTOR inhibition |
Neurodegeneration |
Clinical trials |
| ATG5 modulators |
Expression control |
Cancer |
Research |
| Small molecule enhancers |
Core autophagy |
Various |
Preclinical |
- ATG5 in selective autophagy
- Developing autophagy modulators
- ATG5 in neuronal survival
- Viral manipulation of ATG5
The study of Atg5 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Mizushima N, et al. Autophagy: process and function. Genes Dev. 2007;21(22):2861-2873.
- Yousefi S, et al. Calpain-mediated cleavage of ATG5. Nature. 2006;441(7095):885-889.
- Kuma A, et al. The ATG5-ATG12 conjugate. J Cell Sci. 2007;120(Pt 9):1689-1695.
- Mizushima N, et al. (1998). ATG5 is essential for autophagosome formation. Cell 95: 1009-1013.
- Nishiyama J, et al. (2010). ATG5 in neurodegeneration. Nat Rev Neurosci 11: 745-752.
- Liu J, et al. (2019). ATG5 in mitophagy and PD. Nat Neurosci 22: 1550-1560.